Topic: Science and Technology (general)
Dr. Moira Gunn sits down with Vice President for Drug Discovery and Development, Sanford-Burnham Medical Research Institute, Dr. Micheal Jackson, where they're taking the drudge work out of looking for new drugs using massive robots.
Dr. Moira Gunn talks with Chip Heath, Stanford Professor in Organizational Behaviour, about his new book, Switch, and learn the key to making real change in our lives, no matter what the change is.
Dr. Moira Gunn delves into the differences between diseases and prevention in Asia with Dr. Edward Holmes, Chair of the National Medical Research Council in Singapore.
Dr. Moira Gunn talks about the science behind the decision making process, with noted author, Dr. Sheena Iyengar, from the pages of her new book, The Art of Choosing.
Dr. Moria Gunn sits down to discuss genetics with Dan Nevrivy from the Nevrivy Law Group and BIO's Deputy General Counsel, Hans Sauer. They dig into the Myriad Genetics ruling and analyze why some feel that the global biotech industry has been gutted.
Dr. Moira Gunn talks with VP for Commercial Development and Public Affairs at Dupont Danisco Cellulosic Ethanol, Jack Huttner, about how they brought next-generation ethanol fuel to a small Tennessee town.
Dr. Moira Gunn talks with Mark Emalfarb, CEO of Dyadic International, the entrepreneur who first brought us stonewashed jeans, who now develops novel products from natural proteins, enzymes and polypeptides for the private sector.
Anthony Fassero talks about Wild Style City, a whimsical demo of 3D street-level imaging technology. As CEO of earthmine, Fassero focuses on developing accurate digital representation of environments which facilitate better human interaction. In this Where 2.0 Conference presentation, Fassero discusses some of the potential of 3D street-level imagery using Wild Style City as a fun example.
Dr. Moria Gunn visits with Mark Sherman, CEO of ZoomAtlas, and Wiki inventor, Ward Cunningham, to talk about the latest social networking trend, geo-social networking.
Dr. Moria Gunn interviews VP of Business Development for BioAtla, Leslie Hickle about the concept of buying proteins and antibodies in bulk from their manufacturing facility in China.
